Agios Pharmaceuticals Inc.
AGIO | NASDAQ
$34.88
+$0.93 (+2.74%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 98.34M | 66.05M | 54.03M | 44.79M | 40.88M | 37.04M | 36.5M | 32.87M | 31.31M | 29.4M | 26.82M | 24.03M | 20.15M | 19.02M | 14.24M | 9.93M | 6.41M | 832K | n/a | 44.05M | 78.75M | 116.1M |
Cost of Revenue | 11.88M | 11.84M | 11.52M | 9.64M | 7.37M | 7.49M | 7.11M | 7.84M | 7.69M | 10.17M | 13.14M | 15.95M | 20.32M | 19.96M | 20.26M | 20.08M | 19.65M | 19.13M | 18.78M | 15.13M | 11.19M | 7.17M |
Gross Profit | 86.46M | 54.21M | 42.51M | 35.15M | 33.51M | 29.54M | 29.39M | 25.04M | 23.62M | 19.24M | 13.68M | 8.09M | -176K | -945K | -6.02M | -10.15M | -13.24M | -18.3M | -18.78M | 28.92M | 67.57M | 108.93M |
Operating Income | -459.02M | -475.53M | -472.13M | -475.59M | -461.53M | -440.29M | -425.74M | -406.98M | -405.06M | -392.95M | -391.49M | -384.38M | -374.58M | -378.52M | -389.05M | -394.7M | -394.76M | -388.35M | -378.42M | -366.03M | -365.2M | -364.17M |
Interest Income | 46.3M | 51.09M | 56.38M | 61.98M | 61.67M | 55.28M | 48.08M | 38.69M | 34.01M | 34.14M | 33.34M | 31.21M | 26.65M | 20.19M | 12.79M | 6.64M | 3.08M | 1.28M | 928K | 1.39M | 2.25M | 4.02M |
Pretax Income | -412.3M | -423.62M | -413.8M | -410.14M | 694.33M | 710.23M | 717.97M | 727.43M | -364.93M | -352.62M | -352.09M | -219.62M | -210.05M | -218.05M | -231.8M | -366.91M | -369.42M | -360.41M | -356.51M | -355.58M | -349.38M | -346.32M |
Net Income | -411.29M | -422.6M | -412.78M | -401.27M | 650.08M | 665.99M | 673.73M | 674.31M | -364.93M | -352.62M | -352.09M | -219.62M | -210.05M | -218.05M | -231.8M | -362.95M | -369.36M | -360.97M | -384.42M | -387.45M | -398.28M | -405.34M |
Selling & General & Admin | 192.74M | 187.06M | 180.28M | 180.37M | 177.63M | 167.3M | 156.78M | 140.39M | 127.68M | 119.9M | 114.64M | 109.54M | 110.33M | 108.36M | 111.68M | 110.59M | 108.76M | 109.85M | 111.91M | 122.57M | 132.62M | 141.7M |
Research & Development | 352.75M | 342.68M | 334.36M | 330.38M | 317.41M | 302.54M | 298.35M | 291.62M | 301.01M | 292.29M | 290.53M | 282.92M | 264.07M | 269.21M | 271.35M | 273.96M | 272.77M | 260.19M | 247.73M | 272.38M | 300.14M | 331.4M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 545.49M | 529.74M | 514.64M | 510.75M | 495.04M | 469.84M | 455.13M | 432.01M | 428.68M | 412.18M | 405.17M | 392.47M | 374.4M | 377.57M | 383.02M | 384.55M | 381.53M | 370.04M | 359.64M | 394.94M | 432.77M | 473.1M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 92K | 92K | 6.11M | 15.87M | 17.83M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 557.36M | 541.58M | 526.16M | 520.38M | 502.41M | 477.33M | 462.24M | 439.85M | 436.37M | 422.35M | 418.31M | 408.41M | 394.72M | 397.53M | 403.29M | 404.63M | 401.18M | 389.18M | 378.42M | 410.07M | 443.95M | 480.27M |
Income Tax Expense | -1.02M | -1.02M | -1.02M | -8.88M | 44.24M | 44.24M | 44.24M | 53.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.12M | 2.88M |
Shares Outstanding (Basic) | 59.49M | 58.78M | 58.33M | 58.14M | 57.93M | 57.46M | 57.16M | 56.94M | 56.8M | 56.38M | 55.9M | 55.8M | 55.5M | 55.11M | 54.79M | 54.84M | 54.8M | 54.47M | 54.34M | 57.05M | 61.07M | 69.54M |
Shares Outstanding (Diluted) | 59.49M | 58.78M | 58.33M | 58.14M | 57.93M | 57.46M | 57.16M | 58.43M | 56.8M | 56.38M | 55.9M | 55.8M | 55.6M | 55.27M | 54.79M | 54.84M | 54.8M | 54.56M | 54.34M | 57.05M | 61.07M | 69.54M |
EPS (Basic) | -7.01 | -7.25 | -7.11 | -6.95 | 11.48 | 11.72 | 11.82 | 11.79 | -6.50 | -6.32 | -6.17 | -1.31 | -0.99 | -1.16 | -1.48 | -6.36 | -6.60 | -6.33 | -6.41 | -6.08 | -5.95 | -5.85 |
EPS (Diluted) | -7.01 | -7.25 | -7.11 | -6.95 | 11.05 | 11.29 | 11.39 | 11.36 | -6.50 | -6.32 | -6.16 | -1.30 | -0.98 | -1.15 | -1.48 | -6.36 | -6.60 | -6.33 | -6.41 | -6.08 | -5.95 | -5.85 |
EBITDA | -416.8M | -418.36M | -408.62M | -404.86M | 699.58M | 715.81M | 723.62M | 733.12M | -358.96M | -343.78M | -340.2M | -204.76M | -192.31M | -200M | -213.24M | -348.12M | -350.55M | -341.52M | -337.64M | -332.63M | -339.76M | -347.75M |
EBIT | -422.15M | -423.62M | -413.8M | -410.14M | 694.33M | 710.23M | 717.97M | 727.43M | -364.93M | -352.62M | -352.09M | -219.62M | -210.05M | -218.05M | -231.8M | -366.91M | -369.42M | -360.32M | -356.42M | -349.48M | -354.43M | -360.16M |
Depreciation & Amortization | 5.35M | 5.26M | 5.18M | 5.28M | 5.25M | 5.58M | 5.65M | 5.69M | 5.97M | 8.84M | 11.89M | 14.86M | 17.73M | 18.04M | 18.56M | 18.79M | 18.88M | 18.8M | 18.78M | 16.84M | 14.58M | 12.3M |
Add to Watchlist
Select watchlists to add or remove AGIO